Company / Gross Profit
Cytosorbents Corp Gross Profit History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$15.0M
FY2018
5-year range
$2.0M / $15.0M
FY2014-FY2018
Trend
+55.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2018 with a 5-year CAGR of +71.1%.
Improved from $2M to $15M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +79.9%
- 5-Year CAGR
- +71.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +71.1%, indicating consistent growth.
- In FY2018, gross profit increased 55.9% year-over-year.
- Lowest gross profit in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $15.0M | +55.9% |
| FY2017 | $9.6M | +384.3% |
| FY2016 | $2.0M | -22.9% |
| FY2015 | $2.6M | +29.7% |
| FY2014 | $2.0M | +94.3% |
| FY2013 | $1.0M | +0.0% |
| FY2012 | $1.0M | +4109.4% |
| FY2011 | $24.3K | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026